Skip to main content

Aged care laws in Australia have now changed. The new Aged Care Act 2024 and Aged Care Rules 2025 now apply. While we complete updating of our website, including draft guidance and other materials, to align with the new laws, providers are advised to refer to the new Act and Rules for any required clarification of their obligations and legal responsibilities. Thank you for your patience.

Quality Standards Resource Centre

The Quality Standards Resource Centre helps extend understanding of the strengthened Aged Care Quality Standards, which take effect from 1 November 2025. The Resource Centre will be updated to reflect key changes made to the draft strengthened Standards. You can search for resources by using keywords, or filtering by standard, outcome, audience and theme. Before using the Resource Centre, please read the terms of use.

Displaying 41 to 46 of 46 result(s)
/quality-standards/safe-and-appropriate-use-psychotropic-medicines-aged-care-fact-sheet

Safe and appropriate use of psychotropic medicines for aged care - Fact sheet

Fact sheet
Published date

This fact sheet is informed by the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard (CCS), developed by the Australian Commission on Safety and Quality in Health Care. The CCS describes the safe and appropriate use of psychotropic medicines for people with cognitive disability or impairment, in a way that upholds their rights, dignity, health and quality of life. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

Author
Australian Commission On Safety And Quality In Health Care
Key Theme
Person-centred care, Delivering comprehensive care and services, Medication management
Standard
1: The Individual, 3: The Care and Services, 5: Clinical Care
Outcomes
1.1: Person-centred care, 3.2: Delivery of funded aged care services, 5.3: Safe and quality use of medicines, 5.6 Cognitive impairment  
Safe and appropriate use of psychotropic medicines for aged care - Fact sheet
/quality-standards/clinical-governance-and-quality-improvement-support-medication-management

Clinical governance and quality improvement to support medication management

Guidance
Last Updated

This resource outlines clinical governance and quality improvement systems to support safe medication management. It requires health service organisations to implement systems for procuring, prescribing, dispensing, and monitoring medicines. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

Author
Australian Commission On Safety And Quality In Health Care
Key Theme
Medication management
Standard
5: Clinical Care
Outcomes
5.3: Safe and quality use of medicines
Clinical governance and quality improvement to support medication management
/quality-standards/medicines-use-older-people

Medicines use in older people

Guidance
Published date

This resource is chapter six of the Fourth Atlas 2021 of Healthcare Variations. The chapter examines medicines use in people aged 75 and over, focusing on polypharmacy, medication management reviews (MMRs), and proton pump inhibitor (PPI) dispensing. It highlights variations in medication use and recommends improving access to MMR services and interventions for safe, effective medication use in older populations. 

Author
Australian Commission On Safety And Quality In Health Care
Key Theme
Medication management
Standard
5: Clinical Care
Outcomes
5.3: Safe and quality use of medicines
Medicines use in older people
/quality-standards/electronic-prescribing

Electronic prescribing

Guidance
Last Updated

This resource outlines the framework for electronic prescribing, offering an alternative to paper prescriptions for healthcare providers and consumers. It explains the benefits of electronic prescriptions, such as reducing errors, improving efficiency, and supporting medication safety. The resource also covers technical and legislative requirements for implementing electronic prescriptions in various healthcare settings. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

Author
Department of Health, Disability and Ageing
Key Theme
Medication management, Corporate and clinical governance, Information management system
Standard
5: Clinical Care
Outcomes
5.3: Safe and quality use of medicines, 5.1: Clinical governance
Electronic prescribing
/quality-standards/electronic-prescriptions

Electronic prescriptions

Guidance
Published date
Last Updated

This resource provides an overview of electronic prescriptions, which offer a digital alternative to paper prescriptions. It explains how electronic prescriptions can be issued by healthcare providers and stored on digital devices for convenience. The resource also details the benefits of the Active Script List (ASL) for managing multiple prescriptions, enhancing efficiency and medicine safety.

Author
External resource
Key Theme
Medication management, Information management system, Corporate and clinical governance
Standard
5: Clinical Care
Outcomes
5.3: Safe and quality use of medicines, 5.1: Clinical governance
Electronic prescriptions
/quality-standards/poisons-standard-susmp

The Poisons Standard (the SUSMP)

Guidance
Last Updated

The Poisons Standard (SUSMP) is a resource that classifies medicines and chemicals into schedules for regulatory control in Australia. It outlines guidelines for labelling, packaging, and handling of substances. Key points include updates on scheduling decisions, which assist in public safety, healthcare, and chemical management. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

Author
Department of Health, Disability and Ageing
Key Theme
Medication management
Standard
5: Clinical Care
Outcomes
5.3: Safe and quality use of medicines
The Poisons Standard (the SUSMP)